Featured Post

OOS Investigation Tools: Streamlining Out-of-Specification Investigations

OOS Investigation Tools: Streamlining Out-of-Specification Investigations Out-of-specification (OOS) events are critical occurrences in pharmaceutical manufacturing, representing deviations from established specifications and potentially impacting product quality and patient safety. Efficient and thorough investigations are crucial to identify root causes, prevent recurrence, and ensure product compliance. This post explores essential tools that streamline OOS investigations. Key Tools and Examples of OOS investigation Tools: 1. Electronic Data Capture (EDC) Systems:   These systems are crucial for managing clinical trial data, but their principles of data integrity, audit trails, and secure storage are highly relevant to OOS investigations. Veeva Vault EDC: Veeva is a well-established name in the life sciences industry. Vault EDC is a cloud-based platform specifically designed for clinical data management. Its features like audit trails, electronic signatures, and version contro...

key steps and considerations for monitoring non-viable particulate count in TS facility

Monitoring the non-viable particulate count during terminal sterilization of a product is crucial to ensure the product's quality and safety. Here are some key steps and considerations for monitoring non-viable particulate count:

1. Sampling Locations: 

Determine where to sample within the sterilization chamber or process to get representative data. This may include multiple locations to capture variations.

2. Sampling Method:

Use appropriate sampling methods such as settle plate method, active air sampling, or surface sampling, depending on the nature of the product and the environment.

3. Sampling Frequency:

Establish a sampling frequency based on risk assessment, regulatory requirements, and industry standards. This could be for each sterilization cycle or at regular intervals.

4. Particle Counting:

Use calibrated particle counters to measure the non-viable particulate count accurately. Ensure that the particle counter is suitable for the particle size range of interest.

5. Data Analysis:

Collect and analyze the data to determine trends, identify potential sources of contamination, and assess compliance with specified limits.

6. Documentation:

Maintain thorough documentation of all monitoring activities, including sampling locations, methods, frequencies, results, and any corrective actions taken.

7. Risk Assessment:

Conduct risk assessments periodically to evaluate the impact of non-viable particulates on product quality and patient safety.

8. Continuous Improvement:

Use monitoring data to implement continuous improvement initiatives, such as optimizing sterilization processes, enhancing cleanroom practices, or improving product packaging.

Conclusion:

By following these steps and incorporating best practices, you can effectively monitor the non-viable particulate count during terminal sterilization to maintain product quality and regulatory compliance.

Comments